SEMAGLUTIDE 9mg — Class II drug recall D-0751-2026
Ongoing recall by Apollo Care, LLC, reported 2026-08-19, distributed nationwide. Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
| Recall number | D-0751-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Apollo Care, LLC, Columbia, MO, United States |
| Recall initiated | 2026-07-29 |
| Classified | 2026-08-07 |
| Reported by FDA | 2026-08-19 |
| Distributed | Nationwide (US) |
| Quantity | 24,608 vials |
| Reason classes | specification failure |
| NDC | 71170-0822-02 |
| Lot numbers | AC-017125, AC-017138, AC-017147, AC-017214, AC-017226, AC-017228 |
| Expiration dates | 2026-08-30, 2026-12-31 |
Product
SEMAGLUTIDE 9mg (4.5 mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-822-02
Reason for recall
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0751-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.